ROSEN, A RANKED AND LEADING FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Boston Scientific Corporation common stock between July 23, 2025, and February 3, 2026, of the May 4, 2026, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Boston Scientific common stock during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must file with the Court by May 4, 2026 [3]. - The lawsuit alleges that during the Class Period, Boston Scientific's management made misleading statements about the U.S. Electrophysiology segment's growth, leading to a net income miss and disappointing guidance for the first half of fiscal 2026 [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4].